HAMP and anemia (phenotype): Vadadustat increases iron availability compared with darbepoetin in DD‐CKD–related anemia, as increased serum transferrin (measured as TIBC) is accompanied by decreased transferrin saturation, serum hepcidin, and serum ferritin.